Due to the recent coronavirus or COVID-19 pandemic, the death toll is rising. We hear about many patients who are getting sick with COVID-19 and developing significant health consequences, and unfortunately in many cases not making it out of the hospital.
There has been a lot in the news regarding Ketamine and its use and potential benefits in a variety of mood disorders,- including major depressive disorders. This includes a 2017 article in the American Journal of Psychiatry suggesting Ketamine may be effective in treating suicidality, and subsequently hundreds of articles both in the lay press and medical press have emerged.
Posttraumatic stress disorder, or PTSD, has been described as “complex somatic, cognitive, affective, and behavioral effects of psychological trauma.”
Suicide is a leading cause of death in the United States and the world. According to the Centers for Disease Control and Prevention (CDC), suicide claimed the lives of 47,000 people.
May is Mental Health Awareness Month. We have to continue to shed light on mental health just like we would any other medical based illness. Just like any organ of the body that may need treatment, the heart, the lungs, so does the brain.